Companies
Multinationals Shift Output To Larger Latin American Markets
April 2006 | Market Trend AnalysisRecent months have seen a number of US and European pharmaceutical majors expand in Mexico and Brazil, as low sales and weak regulation take their toll on Latin America's smaller markets. Since the start of 2006, drug majors including BMS, Novartis and Roche have all announced significant shifts in production capacity in the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
